Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. EMQ
  4. Q218
EMQ

EMQ — Extended Matching Question · Review

Question 218

Delivery suite → Haemorrhage

NextGen Workflow Status Needs Review
SQL status generated
Destination eBook
Type EEMQ
UUID 932dc8ca-7faf-4d83-9f7c-42dddf655cf8

Classification

Speciality
Obstetrics and Gynaecology
Group
Clinical
Title
Delivery suite
Topic
Haemorrhage
Subtopic 1
Antepartum haemorrhage
Subtopic 2
General
Subtopic 3
Rhesus prophylaxis
Question Type
EMQ

Question

EEMQ
Question Header
Select the single most appropriate approach to rhesus prophylaxis.
Question Stem
Withhold anti-D if fetal assessment is reassuring

Answer Bank

A Withhold anti-D if fetal assessment is reassuring
B Give anti-D immunoglobulin to a non-sensitised RhD-negative woman following APH, with assessment of fetomaternal haemorrhage where indicated
C Give anti-D only if ultrasound demonstrates placental abruption
D Give anti-D only after delivery
E Anti-D is unnecessary after recurrent APH
F Use maternal haemoglobin to determine anti-D dose
G Give anti-D only when bleeding exceeds 500 mL
H Anti-D is indicated only for placenta praevia

Correct Answer

B. Give anti-D immunoglobulin to a non-sensitised RhD-negative woman following APH, with assessment of fetomaternal haemorrhage where indicated

Explanation

APH is a potentially sensitising event. A non-sensitised RhD-negative woman should receive appropriate anti-D prophylaxis, and testing for fetomaternal haemorrhage is used where required to determine whether additional anti-D is necessary. The indication is not dependent on demonstrating abruption, fetal compromise or a particular visible blood-loss threshold.

Option Validity

A) Reassuring fetal assessment does not remove the sensitisation risk.

C) Anti-D prophylaxis does not depend on ultrasound confirmation of abruption.

D) Prophylaxis is required following the sensitising event rather than being deferred routinely until delivery.

E) Recurrent bleeding does not make prophylaxis unnecessary.

F) Maternal haemoglobin does not determine the magnitude of fetomaternal haemorrhage.

G) Sensitisation can occur without a 500 mL maternal blood-loss threshold.

H) APH from causes other than placenta praevia can also constitute a sensitising event.

Further Reading

RCOG Green-top Guideline No. 63. Antepartum Haemorrhage. Royal College of Obstetricians and Gynaecologists; 2011.

Source & metrics

Authored Difficulty
4.00
Evaluation Score
—
Destination
eBook
Source
—
Source Section
—
Source Locator
—
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question